Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for ...

Natera (NASDAQ:NTRA) reported fourth-quarter 2025 results that management characterized as a record period for testing volume, revenue, and gross margin, while also initiating 2026 financial guidance ...

Natera, Inc. (NASDAQ:NTRA) is one of the best strong buy healthcare stocks to invest in. On February 24, Natera, Inc. (NASDAQ:NTRA) announced results from the SINERGY trial, a Phase 2 study in ...

Natera says it has begun making good on its priorities for 2021, which include expansions in noninvasive prenatal testing (NIPT), transplant rejection testing, minimal residual disease (MRD) cancer ...

Natera (NTRA) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.46 per share. This compares to a loss of $0.41 per share a year ago. These ...

FIRST ON FOX: A tech watchdog has filed a complaint letter with the Securities and Exchange Commission (SEC), alleging that biotech firm Natera misled the public about its prenatal screening ...

SAN CARLOS, Calif., June 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, is pleased to announce the launch of a novel technique to enhance ...

SAN CARLOS, Calif., Sept. 11, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Noridian, the Medicare Administrative ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2025, after the market ...

Natera reported outstanding Q1 2023 financial results, with revenues soaring to $241.8 million, marking a 24.5% increase from the same period in 2022. The company's product revenues witnessed a ...

SAN CARLOS, Calif., Sept. 9, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of the largest non-invasive prenatal test (NIPT ...